Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Tickers AXSM MRNA
Exposures Product Safety
News headline image
Capricor Highlights Two-Year Deramiocel Data as FDA Decision Nears ↗
Via MarketBeat
Tickers CAPR
Exposures Product Safety
News headline image
Kaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) - Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch
Via AB Newswire
Topics Animal Testing Artificial Intelligence
Tickers IGC RIME TOPP VIVS
Exposures Animal Testing Artificial Intelligence Product Safety
News headline image
Why Are Neogen (NEOG) Shares Soaring Today
Via StockStory
Topics Earnings
Tickers NEOG
Exposures Financial Product Safety
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape
Via FinancialNewsMedia
Tickers AVAI BMEA LABT TNDM
Exposures Product Safety
News headline image
Gout Treatments Need A Better Option: XORTX Therapeutics Is Betting XORLO Is It, Targets New Drug Application With FDA Next Year
Via NewMediaWire
Tickers XRTX
Exposures Product Safety
News headline image
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of a Pending Securities Investigation
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026 for a Leadership Role
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Food Plant Cleaning Services Expands National Coverage for Specialized Sanitation and Disinfection
Via Press Advantage
Exposures Product Safety
News headline image
Five-Minute Vagus Nerve Health Assessment for Stressed Adults Announced
Via Press Release Distribution Service
Exposures Product Safety
InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Raises Approximately $5.6 Million in PIPE Financing
Via Investor Brand Network
Tickers TELO
Exposures Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Via Investor Brand Network
Tickers QNTM
Exposures Product Safety
News headline image
AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
Via NewMediaWire
Topics Intellectual Property
Tickers AXIM
Exposures Intellectual Property Product Safety
News headline image
Kaplan Fox Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Act Before the Lead Plaintiff Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
3 Stocks BEAT, MOBX, PRSO Now: FDA Breakthrough, Rare Earths and Military Drones Drive Catalysts
Via AB Newswire
Tickers BEAT MOBX PRSO
Exposures Coal Product Safety
News headline image
Virility Medical Launches in2 Smart Wearable Device in the United States, Bringing New FDA-Cleared Healthcare Technology to US Consumers
Via GlobePRwire
Exposures Product Safety
News headline image
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
BBNX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Beta Bionics, Inc.
Via Newsfile
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
Via Newsfile
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox is Investigating Possible Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Alerts Investors: Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is Under Investigation for Potential Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Understanding How ‘Biosimilar’ Drugs Can Expand Access and Affordability
Via StatePoint Media
Exposures Product Safety
News headline image
Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval ↗
Via MarketBeat
Tickers ARM IVVD
Exposures COVID-19 Product Safety
News headline image
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data ↗
Via MarketBeat
Topics Bonds
Tickers PYPD
Exposures Debt Markets Product Safety
News headline image
Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? ↗
Via The Motley Fool
Tickers GRAL
Exposures Product Safety
News headline image
Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing ↗
Via MarketBeat
Tickers RFL
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.